Response Genetics, Inc

RGDXQ · OTC
Analyze with AI
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Operating Activities
Net Income-$20,184-$13,699-$8,021-$7,757
Dep. & Amort.$1,662$828$633$470
Deferred Tax$1,128$4,980$2,692$534
Stock-Based Comp.$2,834$862$474$818
Change in WC$934-$8,191-$2,741-$2,894
Other Non-Cash$27$920$474$818
Operating Cash Flow-$13,599-$14,300-$6,489-$8,011
Investing Activities
PP&E Inv.-$1,145-$104-$608-$957
Net Acquisitions-$7,495$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$6,000$2-$200$0
Investing Cash Flow-$2,640-$102-$808-$957
Financing Activities
Debt Repay.-$83$8,445-$188-$148
Stock Issued$10,353$0$61,517$16,453
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$126-$8,664-$54,922$0
Financing Cash Flow$10,144$8,469$6,407$16,305
Forex Effect$0$7-$3$4
Net Chg. in Cash-$6,095-$5,926-$893$7,341
Supplemental Information
Beg. Cash$25,554$8,149$9,041$1,700
End Cash$19,459$2,222$8,149$9,041
Free Cash Flow-$14,744-$14,404-$7,097-$8,968